ZTS Zoetis Inc: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Zoetis Corporation (ZTS) - logo korporat

Zoetis Inc. (ZTS) is implementing AI to automate veterinary diagnostics and drug production. The one-year forward EPS growth rate confirms this trajectory, with the value 0.00 recording the metric level. The company is scaling global sales of high-margin vaccines, offsetting R&D expenditures. Stable demand for pet care provides the issuer with a steady cash flow and operational efficiency.

ZTS: Prakiraan wutah bathi saben saham kanggo taun ngarep Zoetis Corporation 04.07.2022 - 15.11.2026

Zoetis Corp (ZTS) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:ZTS, zoetis.com
Produk merek Zoetis Inc

This indicator reflects the daily price action of analyst consensus forecasts for earnings per share (EPS) growth rates for the coming year. For Zoetis Inc. (ZTS), this metric is sensitive to the commercial success of Librela and Solensia, as well as the demand for veterinary care. By analyzing this EPS forecast chart, investors assess market expectations for business scaling. Steady growth in this metric confirms the issuer's fundamental resilience.